Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Chan Tang

3PUBLICATIONS

27CO-AUTHORS

Biologically active moleculesInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Mar 09, 2019

A small-molecule fusion inhibitor of influenza virus is orally active in mice.

Maria J P van Dongen, Rameshwar U Kadam, Jarek Juraszek

|Nov 03, 2018

Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.

Nick S Laursen, Robert H E Friesen, Xueyong Zhu

|Oct 04, 2017

Potent peptidic fusion inhibitors of influenza virus.

Rameshwar U Kadam, Jarek Juraszek, Boerries Brandenburg

Pageof 1

Frequent Collaborators

3 joint publications

Boerries Brandenburg

3 joint publications

Ian A Wilson

3 joint publications

Jan Vermond

2 joint publications

Rameshwar U Kadam

2 joint publications

Jarek Juraszek

2 joint publications

Christophe Buyck

2 joint publications

Wim B G Schepens

2 joint publications

Bart Stoops

2 joint publications

Wouter Goutier

2 joint publications

Maria J P van Dongen

Frequent Collaborators

3 joint publications

Boerries Brandenburg

3 joint publications

Ian A Wilson

3 joint publications

Jan Vermond

2 joint publications

Rameshwar U Kadam

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on : Apr 04, 2011

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on : Jan 09, 2019

See more related videos

Top Related Videos

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on : Apr 04, 2011

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on : Jan 09, 2019

See more related videos